Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03055156 · ClinicalTrials.gov registry record · NA
Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 558
- Enrollment target
NCT03055156: Completed NA study, sponsored by Stanford University.
NCT03055156 is a NA study that has completed, run by Stanford University. The registered enrollment target is 558 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03055156, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 558 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate effects of high rebound mattress toppers (i.e., airweave®) on sleep and sleep-related symptoms. The study will compare effects of use of high rebound mattress toppers versus use of low rebound mattress toppers on sleep and sleep related symptoms and core body temperature during diagnostic sleep studies.
Interventions
- DEVICE Low rebound mattress toppers
- DEVICE High rebound mattress toppers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 558 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-10-19 |
| Phase | NA |
What the finished NCT03055156 record still lists
NCT03055156 is an interventional study that assigns participants to a tested intervention. The registered 558 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which Low rebound mattress toppers is the first listed.
NCT03055156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03055156 about?
NCT03055156 is a clinical study titled "Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms". The purpose of the study is to evaluate effects of high rebound mattress toppers (i.e., airweave®) on sleep and sleep-related symptoms. The study will compare effects of use of high rebound mattress toppers versus use of low rebound mattress toppers on sleep and sleep related symptoms and core body...
What is the current status of trial NCT03055156?
This trial is currently completed. It is a NA study. The enrollment target is 558 participants. The study started on 2015-10. Estimated completion is 2019-10-19.
What interventions are being tested in trial NCT03055156?
The interventions under investigation include: Low rebound mattress toppers (DEVICE), High rebound mattress toppers (DEVICE).
Who is sponsoring clinical trial NCT03055156?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03055156's enrollment target sits among peer trials
558 183rd of 2000 higher than 1,818 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07173751 · 558 participants · Phase 3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia